IL10RA and neoplasm: TC-1 tumour bearing mice were divided randomly into 4 groups: 1) Ex/MPLA/anti-IL-10R antibody immunisation and caerin 1.1/1.9 tumour local administration; 2) Ex/MPLA/anti-IL-10R antibody immunisation plus PBS tumour local injection; 3) caerin 1.1/1.9 tumour local injection and 4) PBS tumour local injection.